Long-term outcome of newly diagnosed epilepsy
-
Group Leader
Professor Patrick Kwan+61 3 9342 7722
Project Details
Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is important to understand the different clinical courses and patterns of response to antiepileptic drugs, ideally by following outcomes from the point of treatment initiation.
This project will perform analysis focusing on response to the initial therapies and their relationship with long-term treatment outcomes and development of pharmacoresistance in newly treated epilepsy patients. The student will be involved in recruiting and following up eligible patients. Basic knowledge and skills in biostatistics is preferred.